Carnegie Investment Counsel’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.2K Hold
100,175
﹤0.01% 546
2026
Q1
$28.9K Hold
100,175
﹤0.01% 558
2025
Q4
$27.3K Sell
100,175
-16,000
-14% -$6.09K ﹤0.01% 563
2025
Q3
$52.8K Sell
116,175
-48,434
-29% -$28.3K ﹤0.01% 550
2025
Q2
$105K Buy
+164,609
New +$151K ﹤0.01% 534
2025
Q1
Sell
-172,609
Closed -$166K 504
2024
Q4
$166K Buy
172,609
+27,412
+19% +$22.6K ﹤0.01% 452
2024
Q3
$132K Hold
145,197
﹤0.01% 460
2024
Q2
$99.2K Hold
145,197
﹤0.01% 463
2024
Q1
$90.5K Buy
145,197
+33,045
+29% +$21.7K ﹤0.01% 491
2023
Q4
$77.4K Sell
112,152
-19,660
-15% -$15.7K ﹤0.01% 480
2023
Q3
$121K Buy
+131,812
New +$139K ﹤0.01% 476

Other funds holding MLSS

Carnegie Investment Counsel's MLSS Position: Q2 2026 in Review

Carnegie Investment Counsel held its Milestone Scientific (MLSS) position steady in Q2 2026 at 100,175 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Carnegie Investment Counsel first reported a position in MLSS in Q3 2023 and has held it in 11 quarters since. The position peaked at $166K in Q4 2024. 12 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.

  • Carnegie Investment Counsel held 100,175 shares of Milestone Scientific worth $32.2K as of Q2 2026.
  • Carnegie Investment Counsel left its Milestone Scientific share count unchanged in Q2 2026.
  • Milestone Scientific made up ﹤0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #546 holding.
  • Carnegie Investment Counsel first reported a position in Milestone Scientific in Q3 2023 and has held it in 11 quarters since.
  • Carnegie Investment Counsel's Milestone Scientific position peaked at $166K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.